Diaceutics (FRA:7DC) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7DC Diaceutics PLC FRA:7DC
91 GF Score
Price €1.60
GF Value €2.15
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Diaceutics FFO per Share?

FFO per Share only applies to REITs.

FRA:7DC
91GF Score
Diaceutics PLC FRA:7DC
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Diaceutics (FRA:7DC) Overvalued in 2026?

Based on GuruFocus' analysis, Diaceutics stock appears to be undervalued. The current stock price of €1.60 is trading 25.6% below its estimated GF Value™ of €2.15. GuruFocus considers Diaceutics to be Modestly Undervalued.

Key valuation signals for FRA:7DC:

  • FFO per Share:
  • GF Value™: €2.15 vs. price of €1.60 (25.6% below fair value)
  • GF Score™: 91/100 with 1 warning sign

No single metric tells the full story. See the FRA:7DC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Diaceutics Business Description

Other Exchanges DIUXF:USADXRX:UK
Address Dataworks at Kings Hall Health & Wellbeing Park, First Floor, Building Two, County Antrim, Belfast, GBR, BT9 6GW
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides integrated commercialization solutions that help biopharma companies maximize patient access, accelerate uptake, and improve the lifetime value of their therapies. The group's services span the full commercial lifecycle, from pre-launch ideas through to mature brand optimization, delivered through an integrated combination of data, technology, and expertise. Its DXRX Data Solutions include DXRX Signal, DXRX Physician Segmentation, DXRX Lab Segmentation, and DXRX Disease Testing Rate Tracker. Geographical market by customer location in the UK, North America, Europe, Asia, and the rest of the world.
91GF Score

Get the complete analysis for FRA:7DC

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.60
Price
€2.15
GF Value